6.21
price down icon0.48%   -0.03
after-market Dopo l'orario di chiusura: 6.18 -0.03 -0.48%
loading
Precedente Chiudi:
$6.24
Aprire:
$6.29
Volume 24 ore:
1.56M
Relative Volume:
0.74
Capitalizzazione di mercato:
$799.19M
Reddito:
$628.25M
Utile/perdita netta:
$-78.55M
Rapporto P/E:
-10.02
EPS:
-0.62
Flusso di cassa netto:
$-29.73M
1 W Prestazione:
-13.51%
1M Prestazione:
-11.29%
6M Prestazione:
-56.21%
1 anno Prestazione:
-57.20%
Intervallo 1D:
Value
$6.20
$6.355
Intervallo di 1 settimana:
Value
$6.20
$7.24
Portata 52W:
Value
$6.08
$19.11

Neogenomics Inc Stock (NEO) Company Profile

Name
Nome
Neogenomics Inc
Name
Telefono
(239) 768-0600
Name
Indirizzo
9490 NEOGENOMICS WAY, FORT MYERS, FL
Name
Dipendente
2,200
Name
Cinguettio
@NeoGenomics
Name
Prossima data di guadagno
2025-02-18
Name
Ultimi documenti SEC
Name
NEO's Discussions on Twitter

Confronta NEO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
NEO
Neogenomics Inc
6.21 924.03M 628.25M -78.55M -29.73M -0.62
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
404.94 160.56B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
188.07 141.52B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
520.87 42.74B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
112.04 34.11B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
158.96 27.70B 15.50B 1.33B 2.16B 7.34

Neogenomics Inc Stock (NEO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-15 Iniziato Guggenheim Neutral
2025-04-30 Downgrade Leerink Partners Outperform → Market Perform
2025-01-13 Downgrade The Benchmark Company Buy → Hold
2024-12-10 Iniziato Jefferies Buy
2024-05-01 Ripresa Craig Hallum Buy
2023-12-29 Reiterato BTIG Research Buy
2023-08-21 Aggiornamento Stephens Equal-Weight → Overweight
2023-05-16 Downgrade Raymond James Outperform → Mkt Perform
2023-05-09 Aggiornamento BTIG Research Neutral → Buy
2023-02-24 Aggiornamento The Benchmark Company Hold → Buy
2023-02-01 Aggiornamento Needham Hold → Buy
2022-08-26 Downgrade The Benchmark Company Buy → Hold
2022-08-22 Downgrade Needham Buy → Hold
2022-06-03 Iniziato Piper Sandler Overweight
2022-03-29 Downgrade BofA Securities Buy → Neutral
2022-03-29 Downgrade Stephens Overweight → Equal-Weight
2022-01-18 Ripresa Stephens Overweight
2021-12-16 Iniziato Cowen Outperform
2021-11-05 Downgrade Morgan Stanley Overweight → Equal-Weight
2021-10-14 Aggiornamento Raymond James Mkt Perform → Outperform
2021-06-03 Iniziato Goldman Buy
2021-02-25 Ripresa Needham Buy
2021-02-25 Downgrade Raymond James Outperform → Mkt Perform
2021-01-28 Iniziato Truist Buy
2020-12-11 Ripresa BTIG Research Buy
2020-10-28 Reiterato Needham Buy
2020-09-09 Iniziato Morgan Stanley Overweight
2020-08-28 Iniziato Guggenheim Buy
2020-07-29 Reiterato Needham Buy
2020-06-25 Iniziato BofA/Merrill Buy
2020-04-21 Ripresa Stephens Overweight
2020-03-02 Ripresa Craig Hallum Buy
2020-02-28 Aggiornamento First Analysis Sec Outperform → Strong Buy
2020-01-23 Downgrade First Analysis Sec Strong Buy → Outperform
2019-10-30 Reiterato Needham Buy
2019-05-01 Reiterato Needham Buy
2019-03-29 Reiterato Needham Buy
2019-01-03 Iniziato Needham Buy
2018-10-24 Aggiornamento First Analysis Sec Outperform → Strong Buy
2018-08-21 Iniziato Leerink Partners Outperform
2018-05-02 Downgrade First Analysis Sec Overweight → Equal-Weight
2017-09-11 Downgrade BTIG Research Buy → Neutral
2017-08-24 Iniziato Gabelli & Co Buy
2016-12-15 Iniziato Cantor Fitzgerald Overweight
Mostra tutto

Neogenomics Inc Borsa (NEO) Ultime notizie

pulisher
Jul 20, 2025

What analysts say about NeoGenomics Inc. stockUnmatched profit potential - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

What drives NeoGenomics Inc. stock priceRapidly expanding wealth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

NeoGenomics Inc. Stock Analysis and ForecastDouble-digit growth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Is NeoGenomics Inc. a good long term investmentBreakthrough wealth creation - Jammu Links News

Jul 19, 2025
pulisher
Jul 19, 2025

Personalized ctDNA monitoring in metastatic HR+/HER2− breast cancer patients during endocrine and CDK4/6 inhibitor therapy - Nature

Jul 19, 2025
pulisher
Jul 18, 2025

Neogenomics Shares Plunge 7.14% Amid Earnings Woes - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know - Yahoo Finance

Jul 18, 2025
pulisher
Jul 17, 2025

Pathological Examination Market Gaining Momentum in Cancer - openPR.com

Jul 17, 2025
pulisher
Jul 16, 2025

NeoGenomics (NASDAQ:NEO investor five-year losses grow to 81% as the stock sheds US$71m this past week - simplywall.st

Jul 16, 2025
pulisher
Jul 15, 2025

Why NeoGenomics Inc. stock attracts strong analyst attention200 Percent Profit Outlook - beatles.ru

Jul 15, 2025
pulisher
Jul 14, 2025

Q1 Earnings Highlights: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Testing & Diagnostics Services Stocks - Yahoo Finance

Jul 14, 2025
pulisher
Jul 11, 2025

NEO Stock Price and Chart — NASDAQ:NEO - TradingView

Jul 11, 2025
pulisher
Jul 11, 2025

NeoGenomics, RadNet, Pediatrix Medical Group, Penumbra, and Neogen Shares Plummet, What You Need To Know - Yahoo Finance

Jul 11, 2025
pulisher
Jul 10, 2025

Press Release: NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025 - 富途牛牛

Jul 10, 2025
pulisher
Jul 05, 2025

NeoGenomics (NEO): A Contrarian Play on Turnaround and Undervaluation - AInvest

Jul 05, 2025
pulisher
Jul 05, 2025

The past five years for NeoGenomics (NASDAQ:NEO) investors has not been profitable - Yahoo Finance

Jul 05, 2025
pulisher
Jul 03, 2025

NeoGenomics Announces Chief Executive Officer Appointment - ACCESS Newswire

Jul 03, 2025
pulisher
Jul 02, 2025

Here’s Why NeoGenomics (NEO) Sold Off in Q1 - Insider Monkey

Jul 02, 2025
pulisher
Jul 02, 2025

NeoGenomics To Participate In Fireside Chat At Stephens 21st Annual Investment Conference - ACCESS Newswire

Jul 02, 2025
pulisher
Jul 01, 2025

NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025 - Bluefield Daily Telegraph

Jul 01, 2025
pulisher
Jun 30, 2025

NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care - The Joplin Globe

Jun 30, 2025
pulisher
Jun 24, 2025

5 Insightful Analyst Questions From NeoGenomics’s Q1 Earnings Call - Yahoo Finance

Jun 24, 2025
pulisher
Jun 18, 2025

NeoGenomics' Market Cap Drops To US$954m Leaving Insiders With Losses - simplywall.st

Jun 18, 2025
pulisher
Jun 18, 2025

NeoGenomics Requests to Dismiss Class Action Filed by Investors - TradingView

Jun 18, 2025
pulisher
Jun 18, 2025

NeoGenomics drops as sequential revenue decline leads to Q1 miss - MSN

Jun 18, 2025
pulisher
Jun 06, 2025

NeoGenomics Schedules its First Quarter 2021 Earnings Release for May 5, 2021 - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 03, 2025

Investor Calendar Invites You to the NeoGenomics Fourth Quarter and Fiscal Year 2015 Earnings Conference Call and Webcast Live on Tuesday March 1, 2016 - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 03, 2025

NeoGenomics at William Blair Conference: Strategic Growth and Innovation By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

NeoGenomics at William Blair Conference: Strategic Growth and Innovation - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

Where are the Opportunities in (NEO) - news.stocktradersdaily.com

Jun 03, 2025
pulisher
Jun 02, 2025

Cancer Tumor Profiling Market Rises with Demand - openPR.com

Jun 02, 2025
pulisher
Jun 02, 2025

Liquid Biopsy Market for Cancer Detection, cfDNA & CTC Analysis | - openPR.com

Jun 02, 2025
pulisher
May 29, 2025

Fort Myers-based NeoGenomics to unveil new cancer diagnostics at ASCO 2025 - Gulfshore Business

May 29, 2025
pulisher
May 29, 2025

NeoGenomics unveils new oncology diagnostics at ASCO 2025 By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 28, 2025

Neogenomics director Kelly buys $38,000 in common stock - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

Neogenomics director Kelly buys $38,000 in common stock By Investing.com - Investing.com Nigeria

May 28, 2025
pulisher
May 28, 2025

NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025 - BioSpace

May 28, 2025
pulisher
May 28, 2025

NeoGenomics unveils new oncology diagnostics at ASCO 2025 - Investing.com

May 28, 2025
pulisher
May 27, 2025

NeoGenomics Approves Key Proposals at Annual Meeting - TipRanks

May 27, 2025
pulisher
May 25, 2025

D. E. Shaw & Co. Inc. Trims Stock Position in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

May 25, 2025
pulisher
May 24, 2025

BNP Paribas Financial Markets Sells 35,979 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

May 24, 2025
pulisher
May 24, 2025

NeoGenomics, Inc. (NASDAQ:NEO) Receives Average Rating of “Hold” from Analysts - Defense World

May 24, 2025

Neogenomics Inc Azioni (NEO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research WAT
$281.66
price down icon 2.04%
diagnostics_research DGX
$166.45
price down icon 0.28%
$140.63
price up icon 1.25%
diagnostics_research LH
$243.04
price down icon 0.28%
diagnostics_research MTD
$1,166.48
price down icon 2.37%
diagnostics_research IQV
$158.96
price down icon 1.04%
Capitalizzazione:     |  Volume (24 ore):